Doctorate Abhishek Bansal: Assistant professor at The oxford medical college hospital and research centre, India

Dr. Abhishek Bansal is a distinguished clinical biochemist with a deep focus on the biochemical underpinnings of diabetes, metabolic syndrome, kidney disorders, and molecular signaling. With an academic background including a Ph.D. in Medical Biochemistry from Malwanchal University, Indore, Dr. Bansal has established himself as a prominent researcher and educator. His work revolves around understanding chronic diseases and their biomarkers, contributing significantly to the advancement of clinical diagnostics. Dr. Bansal has authored 33 publications, including books, book chapters, and research articles, and has participated in numerous international workshops, enhancing his expertise in medical biochemistry and molecular diagnostics. He is currently an Assistant Professor at The Oxford Medical College, Hospital & Research Centre, Bangalore, where he continues to advance the field of biochemistry and mentor the next generation of researchers.

Online Profiles

Education

Dr. Abhishek Bansal’s educational journey is marked by rigorous academic training in medical biochemistry. He completed his Ph.D. in Medical Biochemistry at Malwanchal University, Indore in 2024, where his research focused on the evaluation of biomarkers for chronic kidney disease, a project supervised by Dr. Shreya Nigoskar. His M.Sc. in Medical Biochemistry was awarded by Jawaharlal Nehru Medical College, KAHER, Belagavi in 2020. His master’s thesis explored the correlation between plasma ascorbate levels and Type 2 diabetes management, supervised by Dr. Chetana P. Hadimani. Dr. Bansal’s foundational training began with a B.Sc. in Medical Laboratory Technology from MM(DU), Mullana, Haryana in 2016, where he was introduced to clinical laboratory technologies and methodologies. This combination of academic rigor and hands-on research experience has equipped him with a comprehensive understanding of medical biochemistry and clinical diagnostics.

Research Focus

Dr. Bansal’s research is deeply rooted in the intersection of clinical biochemistry, diabetes, metabolic syndrome, and kidney disorders. His research interests are specifically concentrated on identifying novel biomarkers that could improve the early detection, diagnosis, and management of chronic kidney disease (CKD) and metabolic diseases. He is particularly interested in molecular signaling pathways and their alterations in chronic diseases such as Type 2 diabetes and kidney dysfunction. Dr. Bansal’s recent work has led to an exploration of human neutrophil gelatinase-associated lipocalin (NGAL), asymmetric dimethylarginine (ADMA), and kidney injury molecule-1 (KIM-1) as promising biomarkers for CKD, which could significantly improve clinical outcomes through early intervention.

Experience

Dr. Bansal has accumulated diverse teaching and research experience in academic and clinical settings. He began his teaching career as a Tutor/Demonstrator in the Department of Biochemistry at Government Medical College, Rajouri (Aug 2021 – Apr 2022), where he helped students understand clinical biochemistry concepts and laboratory techniques. He later joined Pt. BDS PGIMS, Rohtak, where he continued in a similar role, further honing his teaching and research skills. Since June 2024, Dr. Bansal has been serving as Assistant Professor in the Department of Biochemistry at The Oxford Medical College, Hospital & Research Centre, Bangalore. In this position, he teaches undergraduate and postgraduate students, mentors research projects, and contributes to departmental initiatives in medical research.

Research Timeline

  • 2024: Ph.D. in Medical Biochemistry, Malwanchal University, Indore – Thesis on kidney disease biomarkers.

  • 2020: M.Sc. in Medical Biochemistry, Jawaharlal Nehru Medical College, KAHER, Belagavi – Research on plasma ascorbate levels in Type 2 diabetes.

  • 2016: B.Sc. in Medical Laboratory Technology, MM(DU), Mullana, Haryana – Gained foundational knowledge in clinical laboratory techniques.

  • Aug 2021 – Apr 2022: Tutor/Demonstrator, Govt. Medical College, Rajouri

  • Apr 2022 – May 2024: Tutor/Demonstrator, Pt. BDS PGIMS, Rohtak

  • Jun 2024 – Present: Assistant Professor, The Oxford Medical College, Hospital & Research Centre, Bangalore

  • 2018-2020: Conducted research on Vitamin C’s impact on Type 2 diabetes as part of M.Sc. thesis.

Awards & Honors

Dr. Bansal’s exceptional contributions to the field of medical biochemistry have earned him several prestigious fellowships and honors. He holds the title of FMIIP (Fellow, Medical and Industrial Institute of Pathology), FMERU (Fellow, Medical Education and Research University), and FMERC (Fellow, Medical and Educational Research Council), marking his academic excellence and contributions to clinical research. These recognitions are a testament to his sustained commitment to advancing medical education and clinical biochemistry.

Top-Noted Publication

Dr. Bansal’s research on chronic kidney disease biomarkers is widely regarded as one of his most impactful contributions. His doctoral thesis titled, “Evaluation of Serum Human Neutrophil Gelatinase-Associated Lipocalin, Asymmetric Dimethylarginine, Kidney Injury Molecule-1, and Beta-Trace Protein as Potential Biomarkers of Chronic Kidney Disease”, has been published in leading international journals. This work is a significant step forward in the identification of non-invasive biomarkers that can aid in the early diagnosis and prognosis of chronic kidney disease. His contributions to biochemistry and nephrology are shaping new approaches in clinical diagnostics.

1. Evaluating Asymmetric Dimethylarginine (ADMA) as a Biomarker for Preeclampsia: A Meta-Analysis

  • Journal: Journal of Neonatal Surgery

  • Year: 2025

  • DOI: 10.52783/jns.v14.1599

  • EID: 2-s2.0-85218718990

  • ISSN: 2226-0439

  • Contributors: Bansal, A.; Hadimani, C.P.; Patil, S.B.; Lah, N.A.Z.B.N.

  • Summary: This meta-analysis evaluates the potential of Asymmetric Dimethylarginine (ADMA) as a reliable biomarker for predicting preeclampsia, a condition that affects pregnant women and can lead to serious complications. This research contributes to improving early detection and management strategies for preeclampsia.

2. Serum Adipsin Levels as a New Marker in Type 2 Diabetes Mellitus: A Meta-Analysis

  • Journal: International Journal of Diabetes in Developing Countries

  • Year: 2025

  • DOI: 10.1007/s13410-025-01449-2

  • EID: 2-s2.0-85217198282

  • ISSN: 0973-3930, 1998-3832

  • Contributors: Bansal, A.; Honnapurmath, V.K.; Singh, A.

  • Summary: This meta-analysis investigates the relationship between serum adipsin levels and Type 2 diabetes mellitus (T2DM). The study highlights adipsin as a promising new biomarker for the disease, offering potential for improved diagnosis and therapeutic strategies in diabetic care.

3. Serum Fetuin-A as a Biomarker for Gestational Diabetes Mellitus: A Meta-Analysis

  • Journal: International Journal of Diabetes in Developing Countries

  • Year: 2025

  • DOI: 10.1007/s13410-025-01507-9

  • EID: 2-s2.0-105007297404

  • ISSN: 0973-3930, 1998-3832

  • Contributors: Bansal, A.; Pragaspathy, V.

  • Summary: This article explores the role of fetuin-A as a potential biomarker for gestational diabetes mellitus (GDM). By conducting a comprehensive meta-analysis, the study supports fetuin-A’s potential in predicting GDM, which could lead to better management and outcomes for pregnant women.

4. AEFI (Adverse Events Following Immunization) Among Children Less Than 2 Years Following Pentavalent Vaccine: A Cross-Sectional Study in India

  • Journal: Journal of Pharmaceutical and Therapeutic Research

  • Year: 2024

  • DOI: 10.53555/jptcp.v31i3.4779

  • Contributors: Dixit, P.; Prashant, P.; Gera, V.; Bansal, A.; Bansal, A.

  • Summary: This cross-sectional study investigates the adverse events following immunization (AEFI) in children under 2 years old in India after receiving the Pentavalent vaccine. The study provides valuable insights into vaccine safety and emphasizes the importance of monitoring adverse events post-vaccination.

5. Development of an Anti-Microbial Starch-Based Polymer Film Embedded with Silver Nanoparticles by Green Synthesis from Tea Extract: A Potential Low-Cost Wound Dressing for Rural Populations in Developing Countries

  • Journal: International Journal of Biomedical Nanoscience and Nanotechnology

  • Year: 2024

  • Report Type: Research Report

  • Contributors: Dinda, S.; Patil, A.B.; Hogade, S.A.; Bansal, A.

  • Summary: This innovative report outlines the development of a starch-based polymer film containing silver nanoparticles, synthesized through a green process using tea extract. The wound dressing, aimed at rural populations in developing countries, offers a low-cost, effective solution for wound care and antimicrobial protection.

Abhishek Bansal, Medicine, Best Researcher Award